[HTML][HTML] Clinical practice guidelines for pain management in acute musculoskeletal injury

JR Hsu, H Mir, MK Wally… - Journal of orthopaedic …, 2019 - journals.lww.com
Purpose: We aimed to produce comprehensive guidelines and recommendations that can
be utilized by orthopaedic practices as well as other specialties to improve the management …

America's opioid epidemic: supply and demand considerations

DJ Clark, MA Schumacher - Anesthesia & Analgesia, 2017 - journals.lww.com
America is in the midst of an opioid epidemic characterized by aggressive prescribing
practices, highly prevalent opioid misuse, and rising rates of prescription and illicit opioid …

Prevention of prescription opioid misuse and projected overdose deaths in the United States

Q Chen, MR Larochelle, DT Weaver, AP Lietz… - JAMA network …, 2019 - jamanetwork.com
Importance Deaths due to opioid overdose have tripled in the last decade. Efforts to curb this
trend have focused on restricting the prescription opioid supply; however, the near-term …

The effect of public insurance expansions on substance use disorder treatment: evidence from the Affordable Care Act

JC Maclean, B Saloner - Journal of Policy Analysis and …, 2019 - Wiley Online Library
We examine the effect of Medicaid expansion under the Affordable Care Act (ACA) on
substance use disorder (SUD) treatment utilization and financing. We combine data on …

Prescription drug monitoring program mandates: impact on opioid prescribing and related hospital use

H Wen, JM Hockenberry, PJ Jeng, Y Bao - Health Affairs, 2019 - healthaffairs.org
Comprehensive mandates for prescription drug monitoring programs (PDMPs) require state-
licensed prescribers and dispensers both to register with and to use the programs in most …

Four states with robust prescription drug monitoring programs reduced opioid dosages

RL Haffajee, MM Mello, F Zhang, AM Zaslavsky… - Health …, 2018 - healthaffairs.org
State prescription drug monitoring programs (PDMPs) aim to reduce risky controlled-
substance prescribing, but early programs had limited impact. Several states implemented …

Changes in buprenorphine-naloxone and opioid pain reliever prescriptions after the Affordable Care Act Medicaid expansion

B Saloner, J Levin, HY Chang, C Jones… - JAMA network …, 2018 - jamanetwork.com
Importance Expanding Medicaid eligibility could affect prescriptions of buprenorphine with
naloxone, an established treatment for opioid use disorder, and opioid pain relievers …

Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions

Y Bao, K Wen, P Johnson, PJ Jeng, ZF Meisel… - Health …, 2018 - healthaffairs.org
Policies and practices have proliferated to optimize prescribers' use of their states'
prescription drug monitoring programs, which are statewide databases of controlled …

Impact of Medicaid expansion on access to opioid analgesic medications and medication-assisted treatment

A Sharp, A Jones, J Sherwood… - … journal of public …, 2018 - ajph.aphapublications.org
Objectives. To assess the impact of the expansion of Medicaid eligibility in the United States
on the opioid epidemic, as measured through increased access to opioid analgesic …

Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993–2014

D Liang, Y Bao, M Wallace, I Grant, Y Shi - Addiction, 2018 - Wiley Online Library
Abstract Background and Aims While the United States has been experiencing an opioid
epidemic, 29 states and Washington DC have legalized cannabis for medical use. This …